DAPT SELECTION AND DURATION BEFORE AND AFTER PCI

Saturday, March 8, 2025

4:30 PM - 5:30 PM ET

Moderator(s)

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

Professor of Cardiology and Population Health Science and Policy, Mount Sinai Endowed Professor in Cardiovascular Clinical Research and Outcomes; Director of Interventional Cardiovascular Research and Clinical Trials; Director of Women’s Heart and Vascular Center at Mount Sinai Heart
Icahn School of Medicine at Mount Sinai, New York
New York, New York, United States

Disclosure information not submitted.

Panel Discussant(s)

Douglas E. Drachman, MD, MSCAI

Director of Education and Director of Interventional Cardiology Fellowship Program
Massachusetts General Hospital
Boston, Massachusetts, United States

No relationships to disclose
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing)
Grant W. Reed, MD, MSc

Program Director, Interventional Cardiology Fellowship
Cleveland Clinic
Cleveland, Ohio, United States

No relationships to disclose
Pieter C. Smits, PhD, FESC

Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): CERC ( centre european of cardiovascular research): Consultant (Ongoing), Stock-privately held company (Ongoing)

Disclosure(s):

Dominick J. Angiolillo, MD, PhD, FSCAI: No financial relationships to disclose

Usman Baber, MD, MS: Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Douglas E. Drachman, MD, MSCAI: No financial relationships to disclose

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI: Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, Sanofi, RM Glo: Grant/Research Support (Ongoing); AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Elixir Medical, Stel, ControlRad (spouse): Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director): SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director) (Ongoing)

Grant W. Reed, MD, MSc: Abbott Laboratories: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)